Nicotine transdermal system step 2 14 mg/24h

Nicotine transdermal system step 2 14 mg/24h patch for smoking cessation. Extended-release nicotine patch for gradual nicotine delivery. Helps manage withdrawal symptoms.

The Nicotine transdermal system step 2 14 mg/24h patch is designed to aid in smoking cessation by delivering nicotine transdermally. This extended-release patch provides a steady dose of nicotine over 24 hours, helping to reduce withdrawal symptoms. It is typically used as part of a comprehensive smoking cessation plan, which may include behavioral therapy and support.

Common effects of using the Nicotine transdermal system step 2 14 mg/24h patch may include skin irritation at the application site, headaches, dizziness, and vivid dreams. Some users may also experience nausea or vomiting. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare professional.

Handle the Nicotine transdermal system step 2 14 mg/24h patch with clean, dry hands to avoid contamination. Apply the patch to a clean, dry, and hairless area of the skin, rotating application sites to prevent irritation. Avoid exposing the patch to high temperatures or prolonged sunlight, as this can affect its effectiveness. Store the patches in a cool, dry place away from children and pets.

The Nicotine transdermal system step 2 14 mg/24h patch may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. It is important to inform your healthcare provider about all medications you are taking before starting this treatment. Additionally, avoid smoking while using the patch, as this can lead to nicotine overdose. Alcohol consumption should also be moderated, as it may exacerbate side effects.